End-of-day quote
Shanghai S.E.
03:30:00 09/05/2024 am IST
|
5-day change
|
1st Jan Change
|
5.7
CNY
|
+0.35%
|
|
+3.07%
|
+3.83%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
13,047
|
21,160
|
17,960
|
13,645
|
11,333
|
11,767
|
-
|
-
|
Enterprise Value (EV)
1 |
13,047
|
21,160
|
17,960
|
13,645
|
11,333
|
11,767
|
11,767
|
11,767
|
P/E ratio
|
19.1
x
|
29.5
x
|
10.7
x
|
13.8
x
|
20
x
|
20.4
x
|
10.4
x
|
11
x
|
Yield
|
2.63%
|
2.39%
|
2.82%
|
2.21%
|
1.51%
|
1.4%
|
1.93%
|
2.28%
|
Capitalization / Revenue
|
0.64
x
|
1.19
x
|
0.77
x
|
0.58
x
|
0.52
x
|
0.53
x
|
0.47
x
|
0.41
x
|
EV / Revenue
|
0.64
x
|
1.19
x
|
0.77
x
|
0.58
x
|
0.52
x
|
0.53
x
|
0.47
x
|
0.41
x
|
EV / EBITDA
|
6.48
x
|
10.6
x
|
5.14
x
|
4.76
x
|
4.36
x
|
3.61
x
|
3.35
x
|
-
|
EV / FCF
|
-
|
-
|
1,18,67,961
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.16
x
|
1.82
x
|
1.4
x
|
1.03
x
|
0.84
x
|
0.84
x
|
0.77
x
|
0.76
x
|
Nbr of stocks (in thousands)
|
20,64,349
|
20,64,349
|
20,64,349
|
20,64,349
|
20,64,349
|
20,64,349
|
-
|
-
|
Reference price
2 |
6.320
|
10.25
|
8.700
|
6.610
|
5.490
|
5.700
|
5.700
|
5.700
|
Announcement Date
|
25/04/20
|
08/04/21
|
16/02/22
|
13/04/23
|
25/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
20,515
|
17,780
|
23,182
|
23,680
|
21,920
|
22,224
|
25,166
|
28,841
|
EBITDA
1 |
2,014
|
1,995
|
3,497
|
2,869
|
2,602
|
3,260
|
3,513
|
-
|
EBIT
1 |
915.3
|
857.4
|
2,316
|
1,710
|
1,432
|
1,449
|
1,951
|
2,211
|
Operating Margin
|
4.46%
|
4.82%
|
9.99%
|
7.22%
|
6.53%
|
6.52%
|
7.75%
|
7.67%
|
Earnings before Tax (EBT)
1 |
936.4
|
885.5
|
2,306
|
1,689
|
1,415
|
1,432
|
1,941
|
2,193
|
Net income
1 |
682.9
|
717.1
|
1,671
|
988.7
|
565.7
|
577
|
1,130
|
1,079
|
Net margin
|
3.33%
|
4.03%
|
7.21%
|
4.18%
|
2.58%
|
2.6%
|
4.49%
|
3.74%
|
EPS
2 |
0.3308
|
0.3474
|
0.8094
|
0.4789
|
0.2740
|
0.2800
|
0.5500
|
0.5200
|
Free Cash Flow
|
-
|
-
|
1,513
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
6.53%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
43.27%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
90.57%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1660
|
0.2450
|
0.2450
|
0.1460
|
0.0830
|
0.0800
|
0.1100
|
0.1300
|
Announcement Date
|
25/04/20
|
08/04/21
|
16/02/22
|
13/04/23
|
25/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
1,513
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
6.14%
|
6.28%
|
13.8%
|
7.63%
|
4.23%
|
4.1%
|
7.38%
|
6.9%
|
ROA (Net income/ Total Assets)
|
2.72%
|
2.92%
|
6.65%
|
3.69%
|
-
|
3.6%
|
4.5%
|
4.9%
|
Assets
1 |
25,070
|
24,548
|
25,141
|
26,798
|
-
|
16,028
|
25,122
|
22,020
|
Book Value Per Share
2 |
5.450
|
5.640
|
6.200
|
6.430
|
6.570
|
6.760
|
7.360
|
7.520
|
Cash Flow per Share
2 |
0.4700
|
1.010
|
0.7700
|
1.170
|
0.8100
|
1.180
|
1.490
|
1.570
|
Capex
1 |
248
|
124
|
61.6
|
367
|
328
|
430
|
606
|
430
|
Capex / Sales
|
1.21%
|
0.7%
|
0.27%
|
1.55%
|
1.5%
|
1.93%
|
2.41%
|
1.49%
|
Announcement Date
|
25/04/20
|
08/04/21
|
16/02/22
|
13/04/23
|
25/04/24
|
-
|
-
|
-
|
Average target price
7.5
CNY Spread / Average Target +31.58% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.83% | 1.62B | | +6.15% | 105B | | -4.19% | 65.16B | | +51.90% | 42.93B | | +17.59% | 39.48B | | +6.89% | 33.27B | | +12.40% | 19.92B | | +16.25% | 17.49B | | +20.35% | 15.43B | | +9.86% | 15.09B |
Other Commodity Chemicals
|